Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Ruthenium-based chemotherapeutics: are they ready for prime timeAntonarakis, Emmanuel S ; Emadi, AshkanCancer chemotherapy and pharmacology, 2010-05, Vol.66 (1), p.1-9 [Periódico revisado por pares]Berlin/Heidelberg: Berlin/Heidelberg : Springer-VerlagTexto completo disponível |
|
2 |
Material Type: Artigo
|
The effect of cyclophosphamide on the immune system: implications for clinical cancer therapyAhlmann, Martina ; Hempel, GeorgCancer Chemotherapy and Pharmacology, 2016-10, Vol.78 (4), p.661-671 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
3 |
Material Type: Artigo
|
Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cellsAggarwal, Sadhna ; John, Sarah ; Sapra, Leena ; Sharma, Suresh C. ; Das, Satya N.Cancer chemotherapy and pharmacology, 2019-03, Vol.83 (3), p.451-461 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
4 |
Material Type: Artigo
|
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristineSilverman, Jeffrey A. ; Deitcher, Steven R.Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.555-564 [Periódico revisado por pares]Berlin/Heidelberg: Springer-VerlagTexto completo disponível |
|
5 |
Material Type: Artigo
|
Advances in ovarian cancer therapyCortez, Alexander J. ; Tudrej, Patrycja ; Kujawa, Katarzyna A. ; Lisowska, Katarzyna M.Cancer chemotherapy and pharmacology, 2018-01, Vol.81 (1), p.17-38 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
6 |
Material Type: Artigo
|
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancerHasegawa, Junichi ; Nishimura, Junichi ; Mizushima, Tsunekazu ; Miyake, Yasuhiro ; Kim, Ho Min ; Takemoto, Hiroyoshi ; Tamagawa, Hroshi ; Noura, Shingo ; Fujii, Makoto ; Fujie, Yujiro ; Kato, Takeshi ; Miwa, Hideaki ; Takemasa, Ichiro ; Ikeda, Masataka ; Yamamoto, Hirofumi ; Sekimoto, Mistugu ; Nezu, Riichiro ; Doki, Yuichiro ; Mori, MasakiCancer chemotherapy and pharmacology, 2014-05, Vol.73 (5), p.1079-1087 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
7 |
Material Type: Artigo
|
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing miceTouil, Yasmine S. ; Seguin, Johanne ; Scherman, Daniel ; Chabot, Guy G.Cancer chemotherapy and pharmacology, 2011-08, Vol.68 (2), p.445-455 [Periódico revisado por pares]Berlin/Heidelberg: Springer-VerlagTexto completo disponível |
|
8 |
Material Type: Artigo
|
Phase I study of a chloroquine–gemcitabine combination in patients with metastatic or unresectable pancreatic cancerSamaras, Panagiotis ; Tusup, Marina ; Nguyen-Kim, Thi Dan Linh ; Seifert, Burkhardt ; Bachmann, Helga ; von Moos, Roger ; Knuth, Alexander ; Pascolo, SteveCancer chemotherapy and pharmacology, 2017-11, Vol.80 (5), p.1005-1012 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
9 |
Material Type: Artigo
|
Application of bee venom and its main constituent melittin for cancer treatmentLiu, Cui-cui ; Hao, Ding-jun ; Zhang, Qian ; An, Jing ; Zhao, Jing-jing ; Chen, Bo ; Zhang, Ling-ling ; Yang, HaoCancer Chemotherapy and Pharmacology, 2016-12, Vol.78 (6), p.1113-1130 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
10 |
Material Type: Artigo
|
The role of thioredoxin system in cancer: strategy for cancer therapyJia, Jin-Jing ; Geng, Wen-Shuo ; Wang, Zhan-Qi ; Chen, Lei ; Zeng, Xian-SiCancer chemotherapy and pharmacology, 2019-09, Vol.84 (3), p.453-470 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |